ENDOSTARSIL HEMOSTAT Trademark

Trademark Overview


On Tuesday, April 16, 2024, a trademark application was filed for ENDOSTARSIL HEMOSTAT with the United States Patent and Trademark Office. The USPTO has given the ENDOSTARSIL HEMOSTAT trademark a serial number of 79399821. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, May 30, 2025. This trademark is owned by Hemostat Manufacturing GmbH. The ENDOSTARSIL HEMOSTAT trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Chemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical tissues, namely, surgical implants comprising living tissues; haemostatic preparations, namely, pharmace...

Medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; orally inserted medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; medical and veterinary endoscopes for colonoscopy for introducing blood clotting agents and blood clotting powder into the human or animal body
endostarsil hemostat

General Information


Serial Number79399821
Word MarkENDOSTARSIL HEMOSTAT
Filing DateTuesday, April 16, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateFriday, May 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemical preparations for medical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for pharmaceutical purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemical preparations for veterinary purposes, namely, for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; chemico-pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade; surgical tissues, namely, surgical implants comprising living tissues; haemostatic preparations, namely, pharmaceutical preparations being hemostatic agents for blood clotting; antihaemophilic factor, namely, pharmaceutical preparations for treating hemophilia; pharmaceutical preparations, namely, blood clotting powder; medical dressing with blood clotting properties; pharmaceutical preparations for improving blood coagulation and supporting natural blood cascade, and for improving blood coagulation and supporting natural blood cascade during and after surgical procedure and emergency treatments; medical plasters, medical dressings, namely, materials for medical dressings; medical dressings; surgical dressings; absorbable surgical dressings; blood clotting, absorbable surgical dressings
NOT AVAILABLE"HEMOSTAT"
Goods and ServicesMedical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; orally inserted medical and veterinary endoscopes for introducing blood clotting agents and blood clotting powder into the human or animal body; medical and veterinary endoscopes for colonoscopy for introducing blood clotting agents and blood clotting powder into the human or animal body

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 11, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHemostat Manufacturing GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, July 11, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 15, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, October 29, 2024ASSIGNED TO EXAMINER
Wednesday, October 30, 2024NON-FINAL ACTION WRITTEN
Thursday, November 7, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 7, 2024REFUSAL PROCESSED BY MPU
Thursday, April 24, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 31, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 23, 2024REFUSAL PROCESSED BY IB
Thursday, April 24, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 24, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 24, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 24, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 29, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 29, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 29, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 30, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 30, 2025EXAMINER'S AMENDMENT ENTERED
Friday, May 30, 2025EXAMINERS AMENDMENT -WRITTEN
Friday, May 30, 2025EXAMINERS AMENDMENT E-MAILED
Friday, May 30, 2025APPROVED FOR PUB - PRINCIPAL REGISTER